To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes.
Latest action · Oct 30, 2019 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 30, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
This bill establishes additional requirements for prescription drug plan (PDP) sponsors that use formularies under the Medicare prescription drug benefit.
Specifically, the bill requires PDP formularies to include covered generic drugs and biosimilars for which the wholesale acquisition cost is less than that of the reference (i.e., brand-name) product. PDP sponsors must also establish specific cost-sharing tiers that apply lower cost-sharing requirements for such covered generic drugs and biosimilars as compared to those for brand-name products.
The bill also prohibits PDP sponsors from instituting certain requirements relating to access to such covered generic drugs and biosimilars that are more restrictive than those for brand-name products (e.g., prior authorization requirements).
Cosponsors 21
Members who signed on, in the order they did. Signatures ran from Oct 30, 2019 to Jan 27, 2020; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NH | Ann M. Kuster | Original | Oct 30, 2019 |
| R-TX | Pete Olson | Nov 12, 2019 | |
| D-VT | Peter Welch | Nov 12, 2019 | |
| D-FL | Darren Soto | Nov 14, 2019 | |
| R-OH | David P. Joyce | Nov 14, 2019 | |
| D-NY | Paul Tonko | Nov 14, 2019 | |
| R-NC | Ted Budd | Nov 14, 2019 | |
| D-MN | Angie Craig | Nov 15, 2019 | |
| R-GA | Earl L. "Buddy" Carter | Nov 15, 2019 | |
| D-CA | Karen Bass | Nov 15, 2019 | |
| R-PA | Guy Reschenthaler | Nov 22, 2019 | |
| D-CA | Salud O. Carbajal | Nov 22, 2019 | |
| D-IL | Bobby L. Rush | Dec 10, 2019 | |
| D-CA | Doris O. Matsui | Dec 10, 2019 | |
| D-CA | Raul Ruiz | Dec 10, 2019 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Oct 30, 2019 |
| Health Subcommittee | Referred Oct 30, 2019 | |
| House | Ways and Means Committee | Referred Oct 30, 2019 |
Actions 3
Everything that happened, newest first.
- Oct 30, 2019Introduced in House
- Oct 30, 2019Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Oct 30, 2019Referred to the Subcommittee on Health.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Lists H8678H.R. 4913–4935 | — | Oct 30, 2019 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 172, October 30, 2019, page H8678.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 2846 | Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021 | Reintroduced Bill | Apr 27, 2021 |
Titles 1
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan under part D of the Medicare program that use a formulary to include certain generic drugs and biosimilar biological products on such formulary, and for other purposes.
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Oct 30, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.